Tenor Capital Management’s Japer Therapeutics, Inc. Warrants JSPRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2K | Hold |
250,000
| – | – | ﹤0.01% | 288 |
|
|
2025
Q1 | $35.8K | Hold |
250,000
| – | – | ﹤0.01% | 213 |
|
|
2024
Q4 | $52.4K | Hold |
250,000
| – | – | ﹤0.01% | 186 |
|
|
2024
Q3 | $50K | Hold |
250,000
| – | – | ﹤0.01% | 167 |
|
|
2024
Q2 | $50K | Hold |
250,000
| – | – | ﹤0.01% | 173 |
|
|
2024
Q1 | $45.5K | Hold |
250,000
| – | – | ﹤0.01% | 202 |
|
|
2023
Q4 | $20K | Hold |
250,000
| – | – | ﹤0.01% | 211 |
|
|
2023
Q3 | $12.5K | Hold |
250,000
| – | – | ﹤0.01% | 249 |
|
|
2023
Q2 | $35.1K | Hold |
250,000
| – | – | ﹤0.01% | 224 |
|
|
2023
Q1 | $50K | Hold |
250,000
| – | – | ﹤0.01% | 260 |
|
|
2022
Q4 | $7.5K | Hold |
250,000
| – | – | ﹤0.01% | 447 |
|
|
2022
Q3 | $15K | Hold |
250,000
| – | – | ﹤0.01% | 543 |
|
|
2022
Q2 | $23K | Hold |
250,000
| – | – | ﹤0.01% | 573 |
|
|
2022
Q1 | $65K | Hold |
250,000
| – | – | ﹤0.01% | 563 |
|
|
2021
Q4 | $368K | Hold |
250,000
| – | – | 0.01% | 481 |
|
|
2021
Q3 | $370K | Hold |
250,000
| – | – | 0.01% | 424 |
|
|
2021
Q2 | $288K | Hold |
250,000
| – | – | 0.01% | 466 |
|
|
2021
Q1 | $205K | Hold |
250,000
| – | – | 0.01% | 480 |
|
|
2020
Q4 | $363K | Hold |
250,000
| – | – | 0.01% | 270 |
|
|
2020
Q3 | $295K | Hold |
250,000
| – | – | 0.01% | 222 |
|
|
2020
Q2 | $250K | Hold |
250,000
| – | – | 0.01% | 157 |
|
|
2020
Q1 | $163K | Buy |
+250,000
| New | +$163K | 0.01% | 152 |
|